AtheroGenics commences phase II trial for treatment of postangioplasty restenosis Oct. 15, 1999 No Comments
Funds from NIST to be used to advance Reprogenesis's lead product into clinic Oct. 14, 1999 No Comments
Solvay launches Aceon tablets in the U.S. for 24-hour control of hypertension Oct. 8, 1999 No Comments
RSS